Wednesday, January 3, 2018

Statement from FDA Commissioner Scott Gottlieb, MD on new steps ... hours ago
The FDA today announced additional steps to encourage generic competition as part of our continued implementation of the Drug Competition Action Plan. This plan has three main components: reducing gaming by branded companies that can delay generic drug entry; resolving scientific and regulatory obstacles that can ...
Post a Comment